dolutegravir/abacavir/lamivudine fixed-dose combination tablet (Formulation B)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dolutegravir/abacavir/lamivudine fixed-dose combination tablet (Formulation B), covering 2011-08-08 to 2011-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets [Phase 1]